Global Pigmentation Disorder Therapeutic Market Research Report 2023

Report ID: 1975270 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pigmentation Disorder Therapeutic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
        1.2.3 Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
    1.3 Market by Application
        1.3.1 Global Pigmentation Disorder Therapeutic Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Dermatology Clinics
        1.3.3 Drugstores and Cosmetic Stores
        1.3.4 Aesthetic Clinics
        1.3.5 E-commerce
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pigmentation Disorder Therapeutic Market Perspective (2017-2028)
    2.2 Pigmentation Disorder Therapeutic Growth Trends by Region
        2.2.1 Pigmentation Disorder Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pigmentation Disorder Therapeutic Historic Market Size by Region (2017-2022)
        2.2.3 Pigmentation Disorder Therapeutic Forecasted Market Size by Region (2023-2028)
    2.3 Pigmentation Disorder Therapeutic Market Dynamics
        2.3.1 Pigmentation Disorder Therapeutic Industry Trends
        2.3.2 Pigmentation Disorder Therapeutic Market Drivers
        2.3.3 Pigmentation Disorder Therapeutic Market Challenges
        2.3.4 Pigmentation Disorder Therapeutic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pigmentation Disorder Therapeutic Players by Revenue
        3.1.1 Global Top Pigmentation Disorder Therapeutic Players by Revenue (2017-2022)
        3.1.2 Global Pigmentation Disorder Therapeutic Revenue Market Share by Players (2017-2022)
    3.2 Global Pigmentation Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pigmentation Disorder Therapeutic Revenue
    3.4 Global Pigmentation Disorder Therapeutic Market Concentration Ratio
        3.4.1 Global Pigmentation Disorder Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pigmentation Disorder Therapeutic Revenue in 2021
    3.5 Pigmentation Disorder Therapeutic Key Players Head office and Area Served
    3.6 Key Players Pigmentation Disorder Therapeutic Product Solution and Service
    3.7 Date of Enter into Pigmentation Disorder Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pigmentation Disorder Therapeutic Breakdown Data by Type
    4.1 Global Pigmentation Disorder Therapeutic Historic Market Size by Type (2017-2022)
    4.2 Global Pigmentation Disorder Therapeutic Forecasted Market Size by Type (2023-2028)
5 Pigmentation Disorder Therapeutic Breakdown Data by Application
    5.1 Global Pigmentation Disorder Therapeutic Historic Market Size by Application (2017-2022)
    5.2 Global Pigmentation Disorder Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pigmentation Disorder Therapeutic Market Size (2017-2028)
    6.2 North America Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
    6.3 North America Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Pigmentation Disorder Therapeutic Market Size (2017-2028)
    7.2 Europe Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
    7.3 Europe Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pigmentation Disorder Therapeutic Market Size (2017-2028)
    8.2 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
    8.3 Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Pigmentation Disorder Therapeutic Market Size (2017-2028)
    9.2 Latin America Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
    9.3 Latin America Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pigmentation Disorder Therapeutic Market Size (2017-2028)
    10.2 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2017-2022)
    10.3 Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Detail
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Pigmentation Disorder Therapeutic Introduction
        11.1.4 Bayer Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
        11.1.5 Bayer Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Detail
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Pigmentation Disorder Therapeutic Introduction
        11.2.4 Allergan Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
        11.2.5 Allergan Recent Development
    11.3 Episciences
        11.3.1 Episciences Company Detail
        11.3.2 Episciences Business Overview
        11.3.3 Episciences Pigmentation Disorder Therapeutic Introduction
        11.3.4 Episciences Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
        11.3.5 Episciences Recent Development
    11.4 La Roche-Posay
        11.4.1 La Roche-Posay Company Detail
        11.4.2 La Roche-Posay Business Overview
        11.4.3 La Roche-Posay Pigmentation Disorder Therapeutic Introduction
        11.4.4 La Roche-Posay Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
        11.4.5 La Roche-Posay Recent Development
    11.5 SkinCeuticals
        11.5.1 SkinCeuticals Company Detail
        11.5.2 SkinCeuticals Business Overview
        11.5.3 SkinCeuticals Pigmentation Disorder Therapeutic Introduction
        11.5.4 SkinCeuticals Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
        11.5.5 SkinCeuticals Recent Development
    11.6 Pierre Fabre
        11.6.1 Pierre Fabre Company Detail
        11.6.2 Pierre Fabre Business Overview
        11.6.3 Pierre Fabre Pigmentation Disorder Therapeutic Introduction
        11.6.4 Pierre Fabre Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
        11.6.5 Pierre Fabre Recent Development
    11.7 Alvogen
        11.7.1 Alvogen Company Detail
        11.7.2 Alvogen Business Overview
        11.7.3 Alvogen Pigmentation Disorder Therapeutic Introduction
        11.7.4 Alvogen Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
        11.7.5 Alvogen Recent Development
    11.8 Obagi
        11.8.1 Obagi Company Detail
        11.8.2 Obagi Business Overview
        11.8.3 Obagi Pigmentation Disorder Therapeutic Introduction
        11.8.4 Obagi Revenue in Pigmentation Disorder Therapeutic Business (2017-2022)
        11.8.5 Obagi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Pigmentation Disorder Therapeutic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.)
    Table 3. Key Players of Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.)
    Table 4. Global Pigmentation Disorder Therapeutic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Pigmentation Disorder Therapeutic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Pigmentation Disorder Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Pigmentation Disorder Therapeutic Market Share by Region (2017-2022)
    Table 8. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Pigmentation Disorder Therapeutic Market Share by Region (2023-2028)
    Table 10. Pigmentation Disorder Therapeutic Market Trends
    Table 11. Pigmentation Disorder Therapeutic Market Drivers
    Table 12. Pigmentation Disorder Therapeutic Market Challenges
    Table 13. Pigmentation Disorder Therapeutic Market Restraints
    Table 14. Global Pigmentation Disorder Therapeutic Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Pigmentation Disorder Therapeutic Market Share by Players (2017-2022)
    Table 16. Global Top Pigmentation Disorder Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pigmentation Disorder Therapeutic as of 2021)
    Table 17. Ranking of Global Top Pigmentation Disorder Therapeutic Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Pigmentation Disorder Therapeutic Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Pigmentation Disorder Therapeutic Product Solution and Service
    Table 21. Date of Enter into Pigmentation Disorder Therapeutic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Pigmentation Disorder Therapeutic Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Pigmentation Disorder Therapeutic Revenue Market Share by Type (2017-2022)
    Table 25. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Pigmentation Disorder Therapeutic Revenue Market Share by Type (2023-2028)
    Table 27. Global Pigmentation Disorder Therapeutic Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Pigmentation Disorder Therapeutic Revenue Market Share by Application (2017-2022)
    Table 29. Global Pigmentation Disorder Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Pigmentation Disorder Therapeutic Revenue Market Share by Application (2023-2028)
    Table 31. North America Pigmentation Disorder Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Pigmentation Disorder Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Pigmentation Disorder Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Pigmentation Disorder Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Pigmentation Disorder Therapeutic Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Pigmentation Disorder Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Pigmentation Disorder Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Pigmentation Disorder Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Bayer Company Detail
    Table 42. Bayer Business Overview
    Table 43. Bayer Pigmentation Disorder Therapeutic Product
    Table 44. Bayer Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
    Table 45. Bayer Recent Development
    Table 46. Allergan Company Detail
    Table 47. Allergan Business Overview
    Table 48. Allergan Pigmentation Disorder Therapeutic Product
    Table 49. Allergan Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
    Table 50. Allergan Recent Development
    Table 51. Episciences Company Detail
    Table 52. Episciences Business Overview
    Table 53. Episciences Pigmentation Disorder Therapeutic Product
    Table 54. Episciences Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
    Table 55. Episciences Recent Development
    Table 56. La Roche-Posay Company Detail
    Table 57. La Roche-Posay Business Overview
    Table 58. La Roche-Posay Pigmentation Disorder Therapeutic Product
    Table 59. La Roche-Posay Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
    Table 60. La Roche-Posay Recent Development
    Table 61. SkinCeuticals Company Detail
    Table 62. SkinCeuticals Business Overview
    Table 63. SkinCeuticals Pigmentation Disorder Therapeutic Product
    Table 64. SkinCeuticals Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
    Table 65. SkinCeuticals Recent Development
    Table 66. Pierre Fabre Company Detail
    Table 67. Pierre Fabre Business Overview
    Table 68. Pierre Fabre Pigmentation Disorder Therapeutic Product
    Table 69. Pierre Fabre Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
    Table 70. Pierre Fabre Recent Development
    Table 71. Alvogen Company Detail
    Table 72. Alvogen Business Overview
    Table 73. Alvogen Pigmentation Disorder Therapeutic Product
    Table 74. Alvogen Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
    Table 75. Alvogen Recent Development
    Table 76. Obagi Company Detail
    Table 77. Obagi Business Overview
    Table 78. Obagi Pigmentation Disorder Therapeutic Product
    Table 79. Obagi Revenue in Pigmentation Disorder Therapeutic Business (2017-2022) & (US$ Million)
    Table 80. Obagi Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pigmentation Disorder Therapeutic Market Share by Type: 2021 VS 2028
    Figure 2. Pharmacological Treatment (Topical Drugs, Hydroquinone, L-Ascorbic Acid, etc.) Features
    Figure 3. Cosmetic Treatment (Chemical Peel, Laser Therapy, Skin Grafting, etc.) Features
    Figure 4. Global Pigmentation Disorder Therapeutic Market Share by Application in 2021 & 2028
    Figure 5. Dermatology Clinics Case Studies
    Figure 6. Drugstores and Cosmetic Stores Case Studies
    Figure 7. Aesthetic Clinics Case Studies
    Figure 8. E-commerce Case Studies
    Figure 9. Others Case Studies
    Figure 10. Pigmentation Disorder Therapeutic Report Years Considered
    Figure 11. Global Pigmentation Disorder Therapeutic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Pigmentation Disorder Therapeutic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Pigmentation Disorder Therapeutic Market Share by Region: 2021 VS 2028
    Figure 14. Global Pigmentation Disorder Therapeutic Market Share by Players in 2021
    Figure 15. Global Top Pigmentation Disorder Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pigmentation Disorder Therapeutic as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Pigmentation Disorder Therapeutic Revenue in 2021
    Figure 17. North America Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Pigmentation Disorder Therapeutic Market Share by Country (2017-2028)
    Figure 19. United States Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Pigmentation Disorder Therapeutic Market Share by Country (2017-2028)
    Figure 23. Germany Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Pigmentation Disorder Therapeutic Market Share by Region (2017-2028)
    Figure 31. China Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Pigmentation Disorder Therapeutic Market Share by Country (2017-2028)
    Figure 39. Mexico Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Pigmentation Disorder Therapeutic Market Share by Country (2017-2028)
    Figure 43. Turkey Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Pigmentation Disorder Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Bayer Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
    Figure 46. Allergan Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
    Figure 47. Episciences Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
    Figure 48. La Roche-Posay Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
    Figure 49. SkinCeuticals Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
    Figure 50. Pierre Fabre Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
    Figure 51. Alvogen Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
    Figure 52. Obagi Revenue Growth Rate in Pigmentation Disorder Therapeutic Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Allergan
Episciences
La Roche-Posay
SkinCeuticals
Pierre Fabre
Alvogen
Obagi
Frequently Asked Questions
Pigmentation Disorder Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pigmentation Disorder Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pigmentation Disorder Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports